Read on to learn about new genomic biomarkers that could improve prognosis and treatment strategies for pancreatic ductal ...

New moles, changes in existing moles, or spots that bleed and don't heal can be signs of skin cancer. Women, especially those ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme ...

CHICAGO (Reuters) - Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that ...

The surgeon general’s report said the lifetime risk of developing any alcohol-related cancer jumped to 19 percent (19 of 100 ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.

Breast reconstruction is a common procedure for women who have undergone mastectomy as part of their breast cancer treatment.